Drug Shortage Report for HEPARIN LEO INJ 1000UNIT/ML

Last updated on 2023-01-31 History
Report ID 181252
Drug Identification Number 00453811
Brand name HEPARIN LEO INJ 1000UNIT/ML
Common or Proper name Sodium Heparin injection
Company Name LEO PHARMA INC
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 1000UNIT
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 10 x 10 mL vial
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-01-17
Estimated end date 2023-01-27
Actual end date 2023-01-30
Shortage status Resolved
Updated date 2023-01-31
Company comments Increase in demand due to competitor out of stock.
Health Canada comments
Tier 3 Status No
Contact Address 3389 STEELES AVENUE EAST, SUITE 110
TORONTO, ONTARIO
CANADA M2H 3S8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-01-31 English Compare
v7 2023-01-30 French Compare
v6 2023-01-30 English Compare
v5 2023-01-18 English Compare
v4 2023-01-17 French Compare
v3 2023-01-17 English Compare
v2 2023-01-17 French Compare
v1 2023-01-17 English Compare

Showing 1 to 8 of 8